Skip to main content

LISINAS FAGICAS COMO ALTERNATIVAS AL TRATAMIENTO ANTIMICROBIANO

PCIN-2017-001

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos Programación Conjunta Internacional
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Strategies to Encapsulate the Staphylococcus aureus Bacteriophage phiIPLA-RODI

  • González-Menéndez, Eva
  • Fernández Llamas, Lucía
  • Gutiérrez, Diana
  • Pando, Daniel
  • Martínez Fernández, Beatriz
  • Rodríguez González, Ana
  • García Suárez, María Pilar
The antimicrobial properties of bacteriophages make them suitable food biopreservatives. However, such applications require the development of strategies that ensure stability of the phage particles during food processing. In this study, we assess the protective effect of encapsulation of the Staphylococcus aureus bacteriophage phiIPLA-RODI in three kinds of nanovesicles (niosomes, liposomes, and transfersomes). All these systems allowed the successful encapsulation of phage phiIPLA-RODI with an efficiency ranged between 62% and 98%, regardless of the concentration of components (like phospholipids and surfactants) used for vesicle formation. Only niosomes containing 30 mg/mL of surfactants exhibited a slightly lower percentage of encapsulation. Regarding particle size distribution, the values determined for niosomes, liposomes, and transfersomes were 0.82 ± 0.09 µm, 1.66 ± 0.21 µm, and 0.55 ± 0.06 µm, respectively. Importantly, bacteriophage infectivity was maintained during storage for 6 months at 4 ◦C for all three types of nanovesicles, with the exception of liposomes containing a low concentration of components. In addition, we observed that niosomes partially protected the phage particles from low pH. Thus, while free phiIPLA-RODI was not detectable after 60 min of incubation at pH 4.5, titer of phage encapsulated in niosomes decreased only 2 log units. Overall, our results show that encapsulation represents an appropriate procedure to improve stability and, consequently, antimicrobial efficacy of phages for application in the food processing industry., This research study was funded by grant AGL2015-65673-R (MINEICO, Program of Science, Technology and Innovation 2013–2017, Spain, EU ANIWHA ERA-NET (BLAAT ID: 67)-PCIN-2017-001 (MINEICO, State Program of Research, Development and Innovation focused to Societal Challenges 2013–2017, Spain). Proyecto Intramural CSIC 201770E016, and GRUPIN14-139 (FEDER EU funds, Principado de Asturias, Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Role of bacteriophages in the implementation of a sustainable dairy chain

  • Gutiérrez, Diana
  • Fernández Llamas, Lucía
  • Rodríguez González, Ana
  • García Suárez, María Pilar
The growing human population is currently facing an unprecedented challenge regarding global food sustainability. Thus, it is of paramount to maintain food production and quality while avoiding a negative impact on climate change and the environment at large. Along the food chain, several practices could compromise future food safety and human health. One example is the widespread use of antibiotics and disinfectants in dairy production, which has contributed to the current antibiotic resistance crisis. Moreover, the uncontrolled release of antimicrobials to the environment poses a significant threat to natural ecosystems. For these reasons, research has recently focused on exploiting natural antimicrobials with the goal of achieving a safer and more sustainable dairy production chain. In this context, bacteriophages, viruses that infect bacteria, may become good allies to prevent and treat diseases in cattle, or be used as disinfectants in dairy facilities and as preservatives in dairy products. This review provides an overview of the current research regarding the use of phages as a global approach to reduce economic losses and food waste, while increasing food safety and reducing the environmental impact of food production. Our current understanding of progress, solutions, and future challenges in dairy production, processing, safety, waste processing, and quality assurance is also discussed., This study was funded by grants AGL2015-65673-R (Ministry of Science and Innovation, Spain), EU ANIWHA ERA-NET (BLAAT ID: 67)/PCIN-2017-001 (Ministry of Economy, Industry and Competitiveness, Spain), Proyecto Intramural CSIC201670E040, Proyecto Intramural CSIC 201770E016, GRUPIN14-139 (Program of Science, Technology and Innovation 2013–2017 and FEDER EU funds, Principado de Asturias, Spain). PG and AR are members of the bacteriophage network FAGOMA II and the FWO Vlaanderen funded “Phagebiotics” research community (WO.016.14), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Characterization of clinical MRSA isolates from northern Spain and assessment of their susceptibility to phage-derived antimicrobials

  • Salas, Marina
  • Wernecki, Maciej
  • Fernández Llamas, Lucía
  • Iglesias, Beatriz
  • Gutiérrez, Diana
  • Álvarez, Andrea
  • García, Laura
  • Prieto, Elisabeth
  • García Suárez, María Pilar
  • Rodríguez González, Ana
Methicillin-resistant Staphylococcus aureus (MRSA) is a prevalent nosocomial pathogen, causing a wide range of diseases. The increased frequency of MRSA isolates in hospitals and the emergence of vancomycin resistance have sparked the search for new control strategies. This study aimed to characterize sixty-seven MRSA isolates collected from both infected patients and asymptomatic carriers in a Spanish hospital. RAPD-PCR allowed the identification of six genetic patterns. We also investigated the presence of genes involved in producing adhesins, toxins and the capsule; the biofilm; and antimicrobial resistance. A notable percentage of the isolates carried virulence genes and showed medium-high ability to form biofilms. Next, we assessed the strains’ susceptibility to two phages (phiIPLA-C1C and phiIPLA-RODI) and one endolysin (LysRODI). All strains were resistant to phiIPLA-C1C, and most (70.2%) were susceptible to phiIPLA-RODI. Regarding LysRODI, all strains displayed susceptibility, although to varying degrees. There was a correlation between endolysin susceptibility and the random amplification of polymorphic DNA (RAPD) profile or the presence of some virulence genes (fnbA, eta, etb, PVL and czr), but that was not observed with biofilm-forming ability, strain origin or phage sensitivity. Taken together, these findings can help to explain the factors influencing endolysin effectiveness, which will contribute to the development of efficient therapies targeting MRSA infections., This research was funded by grants AGL2015-65673-R (MINECO/FEDER, UE, Spain), EU ANIWHA ERA-NET (BLAAT ID: 67), PCIN-2017-001 (AEI/FEDER, UE, Spain) and Proyecto Intramural CSIC 201770E016, IDI/2018/000119 (Program of Science, Technology and Innovation 2018-2020 and FEDER EU funds, Principado de Asturias, Spain). M.S. is a fellow of Scholarships “Introduction to Research” 2018-JAE intro, CSIC. M.W. is a fellow of EIT Food RIS Talents 2019., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Environmental pH is a key modulator of Staphylococcus aureus biofilm development under predation by the virulent phage phiIPLA-RODI

  • Fernández Llamas, Lucía
  • Gutiérrez, Diana
  • García Suárez, María Pilar
  • Rodríguez González, Ana
Previous work had shown that, in some Staphylococcus aureus strains, low concentrations of the virulent phage vB_SauM_phiIPLA-RODI (phiIPLA-RODI) promoted the formation of DNA-rich biofilms, whose cells exhibited significant transcriptional differences compared to an uninfected control. This study aimed to dissect the sequence of events leading to these changes. Analysis of phage propagation throughout biofilm development revealed that the number of phage particles increased steadily up to a certain point and then declined. This partial phage inactivation seemed to be a consequence of medium acidification due to glucose fermentation by the bacterium. Computer simulation of phage–host dynamics during biofilm development showed how even small differences in pH evolution can affect the outcome of phage infection. An acidic pH, together with successful phage propagation, was also necessary to observe the phage-associated changes in biofilm architecture and in the transcriptional profile of the bacterial population. Altogether, this study shows how the dynamics between phage and host can be tightly coordinated through an environmental cue, even in the context of a complex biofilm population., This study was funded by grants PCIN-2017-001 (AEI/FEDER, UE), Proyecto Intramural CSIC 201770E016, and IDI/2018/000119 (Asturias Innovation 2018-2020, Principado de Asturias, Spain and FEDER/EU)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Methicillin-resistant staphylococcus aureus in hospitals: Latest trends and treatments based on bacteriophages

  • Álvarez, Andrea
  • Fernández Llamas, Lucía
  • Gutiérrez, Diana
  • Iglesias, Beatriz
  • Rodríguez González, Ana
  • García Suárez, María Pilar
Even though antibiotic resistance in bacteria is a natural phenomenon, the alarming increase in pathogenic bacteria refractory to a wide range of antimicrobials is attracting attention worldwide. Indeed, the World Health Organization (WHO) has recently published a list of priority pathogens for which new antimicrobial alternatives are urgently needed. Among these pathogens, methicillin-resistant Staphylococcus aureus (MRSA) strains are perhaps the best known by the general public. In addition to its potential to acquire antibiotic resistance, S. aureus can produce a large number of virulence factors, such as hemolysins, enterotoxins, and proteases, and exhibits the ability to form biofilms as well as to evolve into different clones that can spread and colonize new environments. This review provides a brief overview of the latest options in antibacterial therapies, mainly focusing on phage therapy. In this regard, the current stage of research about antimicrobial compounds based on bacteriophages and endolysins against MRSA infections is shown and discussed., This study was funded by grants AGL2015-65673-R (MINECO/FEDER/EU, Spain), EU ANIWHA ERA-NET (BLAAT ID: 67)/PCIN-2017-001 (AEI/FEDER/EU, Spain), Proyecto Intramural CSIC201670E040, Proyecto Intramural CSIC 201770E016, IDI/2018/000119 (Asturias Innovation 2018 to 2020, Principado de Asturias, Spain) and FEDER/EU. P.G. and A.R. are members of the bacteriophage network FAGOMA II and the FWO Vlaanderen-funded “Phagebiotics” research community (WO.016.14), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Gram-Positive Pneumonia: Possibilities Offered by Phage Therapy

  • Fernández Llamas, Lucía
  • Cima-Cabal, María Dolores
  • Duarte, Ana Catarina
  • Rodríguez González, Ana
  • García-Suárez, María del Mar
  • García Suárez, María Pilar
Pneumonia is an acute pulmonary infection whose high hospitalization and mortality rates can, on occasion, bring healthcare systems to the brink of collapse. Both viral and bacterial pneumonia are uncovering many gaps in our understanding of host–pathogen interactions, and are testing the effectiveness of the currently available antimicrobial strategies. In the case of bacterial pneumonia, the main challenge is antibiotic resistance, which is only expected to increase during the current pandemic due to the widespread use of antibiotics to prevent secondary infections in COVID-19 patients. As a result, alternative therapeutics will be necessary to keep this disease under control. This review evaluates the advantages of phage therapy to treat lung bacterial infections, in particular those caused by the Gram-positive bacteria Streptococcus pneumoniae and Staphylococcus aureus, while also highlighting the regulatory impediments that hamper its clinical use and the difficulties associated with phage research, This research was funded by grants UNIR BIO0036; Santander-Crue grant (PN036-2022); Innovative Training Networks (ITN) Marie Skłodowska-Curie Actions H2020-MSCA-ITN-2018. Reference 813439; PID2019-105311RB-I00 (MICIU/AEI/FEDER, UE, Spain; PCIN-2017-001 (AEI/FEDER, UE, Spain); IDI/2018/000119 (Program of Science, Technology and Innovation 2018–2020 and FEDER EU funds, Principado de Asturias, Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Design and Selection of Engineered Lytic Proteins With Staphylococcus aureus Decolonizing Activity

  • Gutiérrez, Diana
  • Rodríguez, Lorena
  • Ruas-Madiedo, Patricia
  • Fernández Llamas, Lucía
  • Campelo, Ana B.
  • Briers, Yves
  • Weiss Nielsen, Martin
  • Pedersen, Karl
  • Lavigne, Rob
  • García Suárez, María Pilar
  • Rodríguez González, Ana
Staphylococcus aureus causes various infections in humans and animals, the skin being the principal reservoir of this pathogen. The widespread occurrence of methicillin-resistant S. aureus (MRSA) limits the elimination and treatment of this pathogen. Phage lytic proteins have been proven as efficient antimicrobials against S. aureus. Here, a set of 12 engineered proteins based on endolysins were conceptualized to select the most optimal following a stepwise funnel approach assessing parameters including turbidity reduction, minimum inhibitory concentration (MIC), time-kill curves, and antibiofilm assays, as well as testing their stability in a broad range of storage conditions (pH, temperature, and ionic strength). The engineered phage lysins LysRODIΔAmi and ClyRODI-H5 showed the highest specific lytic activity (5 to 50 times higher than the rest), exhibited a shelf-life up to 6 months and remained stable at temperatures up to 50°C and in a pH range from 3 to 9. LysRODIΔAmi showed the lower MIC values against all staphylococcal strains tested. Both proteins were able to kill 6 log units of the strain S. aureus Sa9 within 5 min and could remove preformed biofilms (76 and 65%, respectively). Moreover, LysRODIΔAmi could prevent biofilm formation at low protein concentrations (0.15–0.6 μM). Due to its enhanced antibiofilm properties, LysRODIΔAmi was selected to effectively remove S. aureus contamination in both intact and disrupted keratinocyte monolayers. Notably, this protein did not demonstrate any toxicity toward human keratinocytes, even at high concentrations (22.1 μM). Finally, a pig skin ex vivo model was used to evaluate treatment of artificially contaminated pig skin using LysRODIΔAmi (16.5 μg/cm). Following an early reduction of S. aureus, a second dose of protein completely eradicated S. aureus. Overall, our results suggest that LysRODIΔAmi is a suitable candidate as antimicrobial agent to prevent and treat staphylococcal skin infections., This research study was supported by grants Innovative Training Networks (ITN) Marie Skłodowska-Curie Actions H2020-MSCA-ITN-2018 Reference 813439, IDI/2018/000119 (Asturias Innovation 2018–2020, Principado de Asturias, Spain and FEDER/EU) and BLAAT ID 67 (ANIWHA ERA-Net EC Program), PCIN-2017-001 (AEI/FEDER/EU, Spain) and Research Foundation – Flanders (FWO) under grant (G066919N). PG, AR, YB, and RL were members of the FWO Vlaanderen funded “Phagebiotics” research community (WO.016.14) and the bacteriophage network FAGOMA II. LR-R was a Serra Húnter Lecturer.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synergistic action of phage phiIPLA-RODI and lytic protein CHAPSH3b: a combination strategy to target Staphylococcus aureus biofilms

  • Duarte, Ana Catarina
  • Fernández Llamas, Lucía
  • Maesschalck, Vincent de
  • Gutiérrez, Diana
  • Campelo, Ana B.
  • Briers, Yves
  • Lavigne, Rob
  • Rodríguez González, Ana
  • García Suárez, María Pilar
Staphylococcus aureus is considered a priority pathogen due to its increasing acquisition of antibiotic resistance determinants. Additionally, this microbe has the ability to form recalcitrant biofilms on different biotic and inert surfaces. In this context, bacteriophages and their derived lytic proteins may be a forward-looking strategy to help combat staphylococcal biofilms. However, these antimicrobials exhibit individual limitations that may be overcome by combining them with other compounds. This work investigates the combination of a phage-derived lytic protein, CHAPSH3b, and the virulent bacteriophage phiIPLA-RODI. The obtained results show the synergy between both antimicrobials for the treatment of 24-h-old S. aureus biofilms, with greater reductions in viable cell counts observed when phage and lysin are applied together compared to the individual treatments. Time-kill curves and confocal microscopy revealed that the fast antibacterial action of CHAPSH3b reduces the population up to 7 hours after initial exposure, which is subsequently followed by phage predation, limiting regrowth of the bacterial population. Moreover, at least 90% of bacteriophage insensitive mutants are susceptible to the lytic protein. Therefore, CHAPSH3b might help curtail the development of phage resistance during treatment. The combination of the lysin and phiIPLA-RODI also showed promising results in an ex vivo pig skin model of wound infection. Overall, the results of this study demonstrate that the combination of phage-derived lytic proteins and bacteriophages can be a viable strategy to develop improved antibiofilm products., This research study was supported by funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie Grant Agreement No. 813439. In addition, grants IDI/2018/000119 (Program of Science, Technology and Innovation 2018-2020 and FEDER EU, Principado de Asturias, Spain) and EU ANIWHA ERA-NET (BLAAT ID: 67)/PCIN-2017-001 (AEI/FEDER UE) also funded this work. A.C.D. is a fellow from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie Grant Agreement No. 813439. V.M. and D.G are funded by the Research Foundation–Flanders (FWO) under grant G066919N, awarded to Y.B. and R.L.
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Exhaustive variant interaction analysis using multifactor dimensionality reduction

  • Gómez Sánchez, Gonzalo
  • Alonso Parrilla, Lorena
  • Pérez Elena, Miguel Ángel
  • Morán, Ignasi
  • Torrents Arenales, David
  • Berral García, Josep Lluís|||0000-0003-3037-3580
One of the main goals of human genetics is to understand the connections between genomic variation and the predisposition to develop a complex disorder. These disease–variant associations are usually studied in a single independent manner, disregarding the possible effect derived from the interaction between genomic variants. In particular, in a background of complex diseases, these interactions can be directly linked to the disorder and may play an important role in disease development. Although their study has been suggested to help complete the understanding of the genetic bases of complex diseases, this still represents a big challenge due to large computing demands. Here, we take advantage of high-performance computing technologies to tackle this problem by using a combination of machine learning methods and statistical approaches. As a result, we created a containerized framework that uses multifactor dimensionality reduction (MDR) to detect pairs of variants associated with type 2 diabetes (T2D). This methodology was tested on the Northwestern University NUgene project cohort using a dataset of 1,883,192 variant pairs with a certain degree of association with T2D. Out of the pairs studied, we identified 104 significant pairs: two of which exhibit a potential functional relationship with T2D. These results place the proposed MDR method as a valid, efficient, and portable solution to study variant interaction in real reduced genomic datasets., This work was partially financed by the European Commission (EU-HORIZON NEARDATA GA.101092644) and by the Universitat Politècnica de Catalunya (45-FPIUPC2018); it was also partially financed by Generalitat de Catalunya (AGAUR) under grant agreement 2021-SGR-00478; it was also partially financed by the Spanish Ministry of Science (MICINN), the Research State Agency (AEI), and European Regional Development Funds (ERDF/FEDER) under grant agreement PID2021-126248OB-I00, MCIN/AEI/10.13039/501100011033/FEDER, UE., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Exhaustive variant interaction analysis using multifactor dimensionality reduction

  • Gómez Sánchez, Gonzalo
  • Alonso Parrilla, Lorena
  • Pérez Elena, Miguel Ángel
  • Morán, Ignasi
  • Torrents Arenales, David
  • Berral García, Josep Lluís
One of the main goals of human genetics is to understand the connections between genomic variation and the predisposition to develop a complex disorder. These disease–variant associations are usually studied in a single independent manner, disregarding the possible effect derived from the interaction between genomic variants. In particular, in a background of complex diseases, these interactions can be directly linked to the disorder and may play an important role in disease development. Although their study has been suggested to help complete the understanding of the genetic bases of complex diseases, this still represents a big challenge due to large computing demands. Here, we take advantage of high-performance computing technologies to tackle this problem by using a combination of machine learning methods and statistical approaches. As a result, we created a containerized framework that uses multifactor dimensionality reduction (MDR) to detect pairs of variants associated with type 2 diabetes (T2D). This methodology was tested on the Northwestern University NUgene project cohort using a dataset of 1,883,192 variant pairs with a certain degree of association with T2D. Out of the pairs studied, we identified 104 significant pairs: two of which exhibit a potential functional relationship with T2D. These results place the proposed MDR method as a valid, efficient, and portable solution to study variant interaction in real reduced genomic datasets., This work was partially financed by the European Commission (EU-HORIZON NEARDATA GA.101092644) and by the Universitat Politècnica de Catalunya (45-FPIUPC2018); it was also partially financed by Generalitat de Catalunya (AGAUR) under grant agreement 2021-SGR-00478; it was also partially financed by the Spanish Ministry of Science (MICINN), the Research State Agency (AEI), and European Regional Development Funds (ERDF/FEDER) under grant agreement PID2021-126248OB-I00, MCIN/AEI/10.13039/501100011033/FEDER, UE., Peer Reviewed, Postprint (published version)